Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Magalashvili

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Autoimmunity|October 25, 2006
Long term safety of IVIg therapy in multiple sclerosis: 10 years experienceUriel Katz, Irena Kishner, David Magalashvili, et al.
Plos One|October 19, 2012
Suppressed RNA-polymerase 1 pathway is associated with benign multiple sclerosisAnat Achiron, Anna Feldman, David Magalashvili, et al.
Neurobiology of Disease|January 19, 2010
Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosisAnat Achiron, Itamar Grotto, Ran Balicer, et al.
JMIR Serious Games|September 12, 2022
The Design, Development, and Testing of a Virtual Reality Device for Upper Limb Training in People With Multiple Sclerosis: Single-Center Feasibility StudyAlon Kalron, Lior Frid, Iliya Fonkatz, et al.
Neurobiology of Disease|March 23, 2024
Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulationAnat Achiron, Rina Falb, Shay Menascu, et al.
BMC Neurology|November 22, 2015
Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosisMichael Gurevich, Gadi Miron, Rina Zilkha Falb, et al.
Scientific Reports|March 8, 2022
Longitudinal relationships between disability and gait characteristics in people with MSSapir Dreyer-Alster, Shay Menascu, Mark Dolev, et al.
Journal of Neurovirology|May 13, 2016
Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patientsAnat Achiron, Gadi Miron, Rina Zilkha-Falb, et al.
Annals of Clinical and Translational Neurology|November 16, 2020
Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patientsShay Menascu, Yulia Khavkin, Rina Zilkha-Falb, et al.
Journal of Neuroimmunology|September 26, 2022
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4David Magalashvili, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Autoimmunity|October 25, 2006
Long term safety of IVIg therapy in multiple sclerosis: 10 years experienceUriel Katz, Irena Kishner, David Magalashvili, et al.
Plos One|October 19, 2012
Suppressed RNA-polymerase 1 pathway is associated with benign multiple sclerosisAnat Achiron, Anna Feldman, David Magalashvili, et al.
Neurobiology of Disease|January 19, 2010
Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosisAnat Achiron, Itamar Grotto, Ran Balicer, et al.
JMIR Serious Games|September 12, 2022
The Design, Development, and Testing of a Virtual Reality Device for Upper Limb Training in People With Multiple Sclerosis: Single-Center Feasibility StudyAlon Kalron, Lior Frid, Iliya Fonkatz, et al.
Neurobiology of Disease|March 23, 2024
Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulationAnat Achiron, Rina Falb, Shay Menascu, et al.
BMC Neurology|November 22, 2015
Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosisMichael Gurevich, Gadi Miron, Rina Zilkha Falb, et al.
Scientific Reports|March 8, 2022
Longitudinal relationships between disability and gait characteristics in people with MSSapir Dreyer-Alster, Shay Menascu, Mark Dolev, et al.
Journal of Neurovirology|May 13, 2016
Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patientsAnat Achiron, Gadi Miron, Rina Zilkha-Falb, et al.
Annals of Clinical and Translational Neurology|November 16, 2020
Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patientsShay Menascu, Yulia Khavkin, Rina Zilkha-Falb, et al.
Journal of Neuroimmunology|September 26, 2022
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4David Magalashvili, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Pageof 4